Surefire collects $16.4M to expand cancer-drug catheter biz

Colorado startup Surefire Medical picked up $16.4 million from 30 investors to support expansion of its operations, according to a report in the Denver Business Journal. The four-year-old startup develops cancer-drug delivering catheters, which are designed to administer treatment directly to tumors through a process called chemoembolization. The device gained FDA approval in 2011 and a CE mark this year. The Journal reports that Surefire offered to sell as much as $21.3 million in equity. Article

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.